SDS

Monsanto Company, Lawn & Garden Products
Page: 2 / 10
Roundup® Ready-To-Use Weed & Grass Killer III Version: 2.0 Effective date: 10/15/2015
If eye irritation persists:Get medical advice/attention.
2.3. Appearance and odour (colour/form/odour)
Hazy /Liquid / Musky, Slight
2.4. OSHA Status
This product is hazardous according to the OSHA Hazard Communication Standard, 29 CFR 1910.1200.
Refer to section 11 for toxicological and section 12 for environmental information.
3. COMPOSITION/INFORMATION ON INGREDIENTS
Active ingredient
Isopropylamine salt of N-(phosphonomethyl)glycine; {Isopropylamine salt of glyphosate}
Nonanoic and related fatty acids; {Pelargonic and related fatty acids}
Composition
COMPONENT CAS No. % by weight (approximate)
Isopropylamine salt of glyphosate 38641-94-0 2
Pelargonic and related fatty acids 112-05-0 2
Water and minor formulating ingredients 96
The specific chemical identity is being withheld because it is trade secret information of Monsanto Company.
4. FIRST AID MEASURES
Use personal protection recommended in section 8.
4.1. Description of first aid measures
4.1.1. Eye contact: If in eyes, hold eye open and rinse slowly and gently for 15-20 minutes. Remove
contact lenses, if present, after first 5 minutes, then continue rinsing. Call a poison control center or
doctor for treatment advice.
4.1.2. Skin contact: Take off contaminated clothing. Rinse skin immediately with plenty of water for 15-
20 minutes. Call a poison control center or doctor for treatment advice.
4.1.3. Inhalation: If inhaled, move person to fresh air. If person is not breathing, call emergency number or
ambulance, then give artificial respiration, preferably mouth-to-mouth, if possible. Call a poison
control center or doctor for treatment advice.
4.1.4. Ingestion: Call poison control center or doctor immediately for treatment advice. Have person sip a
glass of water if able to swallow. Do not induce vomiting unless told to do so by the poison center or
doctor. Do not give anything by mouth to an unconscious person.
4.2. Most important symptoms and effects, both acute and delayed
4.2.1. Eye contact, short term: Causes moderate but temporary eye irritation.
4.2.2. Skin contact, short term: Not expected to produce significant adverse effects when recommended
use instructions are followed.
4.2.3. Inhalation, short term: Not expected to produce significant adverse effects when recommended use
instructions are followed.
4.2.4. Single ingestion: Not expected to produce significant adverse effects when recommended use
instructions are followed.
4.3. Indication of any immediate medical attention and special treatment needed